PFM Health Sciences’s Alibaba BABA Stock Holding History

PFM Health Sciences’s Portfolio BABA Stock Details BABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-156,000	Closed	-$28.9M	–	119
2018 Q2	$28.9M	Buy	+156,000	New	+$29.7M	0.45%	79

Other funds holding BABA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PFM Health Sciences's BABA Position: Q2 2020 in Review

PFM Health Sciences sold out of Alibaba (BABA) in Q2 2020, closing a stake of 70,083 shares — an estimated $13.6M sold.

PFM Health Sciences first reported a position in BABA in Q4 2015 and held it in 17 quarters. The position peaked at $99.1M in Q2 2017. 1,772 funds tracked by Wall St. Rank hold BABA as of Q2 2020.

PFM Health Sciences reported no remaining Alibaba position as of Q2 2020 after selling out during the quarter.
PFM Health Sciences sold 70,083 Alibaba shares in Q2 2020, an estimated $13.6M.
PFM Health Sciences first reported a position in Alibaba in Q4 2015 and held it in 17 quarters.
PFM Health Sciences's Alibaba position peaked at $99.1M in Q2 2017.
1,772 funds tracked by Wall St. Rank held Alibaba as of Q2 2020.

Based on PFM Health Sciences's 13F filing for Q2 2020, filed 14 Aug 2020.